Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX in Advanced and Metastatic Pancreatic Cancer
NCT00261092Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in pancreatic adenocarcinoma (PDAC), sponsored by Sanofi. Started Oct 2005; status: completed.
02
Drugs
oxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00261092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261092.